Knoll Capital Management, LLC — 13F Holdings & Portfolio
CIK 1325083 · latest 13F-HR filed 2026-09-10
Knoll Capital Management, LLC manages $214.3M in 13F-reported U.S. long-equity assets across 37 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are Biohaven Pharmactl Hldg Co (16.33%), MGTX (7.88%), PHYS (5.45%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position and exited 1; 12 existing positions rose in reported value and 20 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-09-10
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 62%Cumulative share of the portfolio held in the largest N positions.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- Biohaven Pharmactl Hldg Co$15.3M +77.7%
- OR Royalties$7.1M +83088.2%
- Ocular Therapeutix Inc.$6.2M +122.1%
- MeiraGTX Holdings$6.1M +56.0%
- Booz Allen Hamilton HLDG COR$4.7M +461.3%
Top Trims
- Royal Gold Inc.-$2.9M -21.6%
- Agnico Eagle Mines Ltd-$2.5M -23.6%
- Kinross Gold Corp-$2.2M -22.6%
- Sprott physical gold Trust-$2.0M -14.9%
- Elicio Therapeutics Inc-$2.0M -29.7%
Knoll Capital Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | Biohaven Pharmactl Hldg Co | — | G11196105 | $35.0M | 16.33% | 2,352,520 | SH |
| 2 | MeiraGTX Holdings | MGTX | G59665102 | $16.9M | 7.88% | 1,250,000 | SH |
| 3 | Sprott physical gold Trust | PHYS | 85207H104 | $11.7M | 5.45% | 387,055 | SH |
| 4 | Aldeyra Therapeutics Inc | ALDX | 01438T106 | $11.7M | 5.44% | 5,475,516 | SH |
| 5 | Ocular Therapeutix Inc. | OCUL | 67576A100 | $11.3M | 5.27% | 1,150,400 | SH |
| 6 | Royal Gold Inc. | RGLD | 780287108 | $10.5M | 4.91% | 52,750 | SH |
| 7 | Entera Bio Ltd | ENTX | M40527109 | $10.4M | 4.86% | 5,881,879 | SH |
| 8 | Nuvation Bio Inc | NUVB | 67080N101 | $9.1M | 4.24% | 1,598,591 | SH |
| 9 | Agnico Eagle Mines Ltd | AEM | 008474108 | $8.2M | 3.82% | 52,750 | SH |
| 10 | SEABRIDGE GOLD INC | SA | 811916105 | $8.2M | 3.81% | 317,003 | SH |
| 11 | Kinross Gold Corp | KGC | 496902404 | $7.6M | 3.53% | 320,000 | SH |
| 12 | OR Royalties | OR | 68390D106 | $7.1M | 3.32% | 225,000 | SH |
| 13 | SSR Mining In | SSRM | 784730103 | $6.9M | 3.23% | 245,000 | SH |
| 14 | Franco Nev Corp | FNV | 351858105 | $6.7M | 3.11% | 32,000 | SH |
| 15 | Booz Allen Hamilton HLDG COR | BAH | 099502106 | $5.7M | 2.66% | 13,000 | SH |
| 16 | Centerra Gold Inc | CGAU | 152006102 | $5.7M | 2.66% | 359,000 | SH |
| 17 | Elicio Therapeutics Inc | ELTX | 28657F103 | $4.7M | 2.21% | 1,211,957 | SH |
| 18 | Abivax SA Spons | ABVX | 00370M103 | $4.7M | 2.18% | 35,000 | SH |
| 19 | Pan American Silver | PAAS | 697900108 | $4.5M | 2.09% | 100,035 | SH |
| 20 | Sprott Physical silver Trust | PSLV | 85207K107 | $4.2M | 1.96% | 222,160 | SH |
| 21 | Triple Flag Precious Metals | TFPM | 89679M104 | $3.4M | 1.61% | 115,000 | SH |
| 22 | Abeona Therapeutics | ABEO | 00289Y206 | $3.0M | 1.40% | 485,515 | SH |
| 23 | Gold RTY Corp | GROY | 38071H106 | $2.8M | 1.29% | 1,000,000 | SH |
| 24 | New Pac Metals Corp | NEWP | 64782A107 | $1.9M | 0.91% | 485,000 | SH |
| 25 | iSHares US Aerospace & Defense | ITA | 464288760 | $1.9M | 0.87% | 7,650 | SH |
| 26 | Philip Morris Intl. Inc | PM | 718172109 | $1.8M | 0.84% | 10,000 | SH |
| 27 | Coeur Mining Inc | CDE | 192108504 | $1.6M | 0.73% | 96,132 | SH |
| 28 | Alamos Gold Inc | AGI | 011532108 | $1.5M | 0.71% | 50,000 | SH |
| 29 | Wheaton Precious Metals Corp | WPM | 962879102 | $1.4M | 0.66% | 12,500 | SH |
| 30 | Northrop Grumman Corp | NOC | 666807102 | $1.1M | 0.51% | 2,165 | SH |
| 31 | Elemental RTY Corp | ELE | 28620K106 | $873.0K | 0.41% | 50,000 | SH |
| 32 | Versamet Royalties Corp | VMET | 92528V200 | $820.7K | 0.38% | 66,621 | SH |
| 33 | Dakota Gold Corp | DC | 46655E100 | $523.6K | 0.24% | 122,921 | SH |
| 34 | Amrize LTD | AMRZ | H2927K103 | $489.0K | 0.23% | 9,175 | SH |
| 35 | Altimmune Inc | ALT | 02155H200 | $486.4K | 0.23% | 160,000 | SH |
| 36 | Pharming Group NV | PHAR | 71716E105 | $56.8K | 0.03% | 4,091 | SH |
| 37 | Orgenesis, Inc. | ORGS | 68619K105 | $20.8K | 0.01% | 50,623 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $179.3M | 37 | 0001104659-26-097070 |
| 2026-06-30 | 2026-09-10 | $214.3M | 37 | 0001104659-26-106457 |
| 2026-03-31 | 2026-05-15 | $180.2M | 37 | 0001104659-26-062445 |
| 2025-12-31 | 2026-02-17 | $218.0M | 34 | 0001104659-26-016376 |
| 2025-09-30 | 2025-11-14 | $186.6M | 39 | 0001104659-25-112578 |
SUITE 800
MIAMI, FL 33131